The present study was aimed at (1) identifying novel TAAR1 agonists, chemically distinct from known chemical classes, and (2) testing the compounds found to be active at the TAAR1 receptor for their effects in vivo using animal models relevant to schizophrenia. The gene discussed is TAAR1; the disease is schizophrenia.